Healthcare provider profile · identity verified

Aleksandra Kolnick, DO

Internal Medicine · BURLINGTON, MA · NPI 1336708213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	201
Lisinopril	Lisinopril	330	122
Amlodipine Besylate	Amlodipine Besylate	291	119
Omeprazole	Omeprazole	217	80
Losartan Potassium	Losartan Potassium	204	74
Levothyroxine Sodium	Levothyroxine Sodium	203	72
Gabapentin	Gabapentin	169	65
Rosuvastatin Calcium	Rosuvastatin Calcium	166	60
Hydrochlorothiazide	Hydrochlorothiazide	147	57
Simvastatin	Simvastatin	140	52
Metoprolol Succinate	Metoprolol Succinate	126	53
Lorazepam	Lorazepam	111	50
Pantoprazole Sodium	Pantoprazole Sodium	93	31
Atenolol	Atenolol	86	31
Tamsulosin Hcl	Tamsulosin Hcl	77	32
Warfarin Sodium	Warfarin Sodium	74	11
Metformin Hcl Er	Metformin Hcl	72	33
Tramadol Hcl	Tramadol Hcl	71	37
Zolpidem Tartrate	Zolpidem Tartrate	66	23
Albuterol Sulfate Hfa	Albuterol Sulfate	64	22
Metformin Hcl	Metformin Hcl	62	28
Oxycodone Hcl	Oxycodone Hcl	62	26
Sertraline Hcl	Sertraline Hcl	60	20
Fluticasone Propionate	Fluticasone Propionate	59	31
Alprazolam	Alprazolam	58	21
Clonazepam	Clonazepam	56	13
Trazodone Hcl	Trazodone Hcl	56	24
Metoprolol Tartrate	Metoprolol Tartrate	50	22
Famotidine	Famotidine	49	18
Allopurinol	Allopurinol	48	18
Furosemide	Furosemide	48	15
Eliquis	Apixaban	45	21
Spironolactone	Spironolactone	45	16
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	17
Mirtazapine	Mirtazapine	32	suppressed
Xarelto	Rivaroxaban	32	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Ezetimibe	Ezetimibe	29	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Potassium Chloride	Potassium Chloride	26	16
Escitalopram Oxalate	Escitalopram Oxalate	25	14
Ozempic	Semaglutide	25	11
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Finasteride	Finasteride	24	13
Jardiance	Empagliflozin	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	13
Synthroid	Levothyroxine Sodium	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Valsartan	Valsartan	22	11
Propranolol Hcl	Propranolol Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	18	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	16
Diazepam	Diazepam	18	suppressed
Pregabalin	Pregabalin	18	11
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Azithromycin	Azithromycin	15	15
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Azelastine Hcl	Azelastine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Prednisone	Prednisone	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Glipizide	Glipizide	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error